Vaccines

Featured

Image pmed.1001403.blog_.jpg

U.S. Must Increase Capacity For Global Health R&D, Anticipate Global Disease Threats

Washington Post: Why aren’t we producing medications for looming global disease threats? Mel Spigelman, physician and president and chief executive of TB Alliance “…[A new Global Health Technologies Coalition] analysis reveals that over the past six years, [U.S.] taxpayer funding for global health research has been stagnant or declining. … Managing health threats through emergency…More

no image

Working Towards an Achievable Goal: A World without CRS

Susan Reef, MD, Rubella Team Lead, Global Immunization Division When I started focusing on rubella in 1994, it was mainly recognized as a significant public health problem in high-income countries. When the public health community realized that rubella and congenital rubella syndrome (CRS) were actually significant public health issues in the entire region of the Americas, things took a turn and an elimination goal was set for 2010. In the pre-vaccine era, some 20,000 infants were born each year in the Americas region with CRS and one or more of its devastating birth defects. I look at our success in achieving the elimination goal —which occurred in 2009, a year before the target date—in terms of the lives it impacted: 20,000 of them, born free of CRS disabilities each year since then.

Ebola, Access to Medicines, and the Health Impact Fund

In this piece in the Journal of Global Health, Yale philosopher Dr. Thomas Pogge, the co-founder of the Health Impact Fund (HIF), and I look into the systemic Read More

Latest

NIH Confirms Safety Of 2 Experimental Ebola Vaccines

Reuters: Two experimental Ebola vaccines pass safety test in African trial “Two experimental Ebola vaccines, one from GlaxoSmithKline PLC and the other from biotech start-up NewLink Genetics Corp, ‘appear to be safe’ part way through a clinical trial being conducted in Liberia, the U.S. National Institutes of Health (NIH) said on Thursday…” (Begley, 3/26). Wall…More


U.S. Must Increase Capacity For Global Health R&D, Anticipate Global Disease Threats

Image pmed.1001403.blog_.jpg

Washington Post: Why aren’t we producing medications for looming global disease threats? Mel Spigelman, physician and president and chief executive of TB Alliance “…[A new Global Health Technologies Coalition] analysis reveals that over the past six years, [U.S.] taxpayer funding for global health research has been stagnant or declining. … Managing health threats through emergency…More


Equitable Access To Vaccines Critical To Children’s Health

Bill & Melinda Gates Foundation’s “Impatient Optimists”: Be Bold: How Gavi Will Immunize Another 300 Million Children Dagfinn Høybråten, chair of the Board of Gavi, The Vaccine Alliance and secretary general of the Nordic Council of Ministers, discusses the challenges of immunizing children around the globe and the importance of establishing “equitable, sustainable vaccine programs”…More


Mistrust, Lack Of Ebola Cases Pose Challenges To Vaccine Trials, Prevention Efforts

New York Times: Vaccines Face Same Mistrust That Fed Ebola “…[T]he United States is helping to lead a large study of two vaccines against Ebola. But as researchers try to compress a clinical process that can take a decade into a fraction of the time, they are confronting the same volatile mix of skepticism, fear,…More


Successful Rural Health Programs Need Service Integration

Bill & Melinda Gates Foundation’s “Impatient Optimists”: Vaccine Heroes and the Work Ahead Using a small Indian village as an example, Helen Matzger, senior program officer on the Vaccine Delivery Team at the Gates Foundation, discusses “the importance of working to ensure health services are integrated across vaccines, family planning, nutrition, and water and sanitation,…More


Researchers Hit Snags In Testing Ebola Treatments, Vaccines

Al Jazeera America: Why we’re still waiting on an Ebola vaccine “Since Ebola hit [Freetown, Sierra Leone,] last summer, nurses at Connaught Hospital have put their lives on the line by working with patients at risk of the deadly disease. Now researchers aim to recruit them as well as ambulance drivers and other hospital staff…More


Middle East’s Gulf States, Donors Well-Positioned To Help Improve Global Health

Arabian Business: Bill Gates: Why I’m betting on the Gulf to help fight extreme poverty and disease Bill Gates, co-chair of the Bill & Melinda Gates Foundation “…I saw the Middle East’s role in global health first-hand in late January, at a conference in Berlin dedicated to providing life-saving vaccines to children in low-income countries…More


An analysis of government immunization program expenditures in lower and lower middle income…

Financing is becoming increasingly important as the cost of immunizing the world’s children continues to rise.


Ebola Vaccine Trial Using Ring Strategy To Launch In Guinea; Researchers Learn From Ebola…

CIDRAP News: Ebola ring vaccination trial set for Guinea launch “The World Health Organization (WHO) announced today that a phase 3 trial of a Canadian-developed Ebola vaccine will launch this week in Guinea, with a ring vaccination strategy designed to test if vaccines might be useful for stamping out hot spots in outbreak settings. In…More


Gates Foundation To Invest $52M In German Biotech Company, To Work Together To Develop…

Reuters: Gates Foundation makes its biggest-ever equity investment in German biotech “The Bill & Melinda Gates Foundation said it would invest $52 million in CureVac, a German biotechnology company that develops vaccines and immunotherapies, marking the foundation’s biggest-ever equity investment. … The foundation will also fund multiple projects developing vaccines for viral, bacterial, and parasitic…More


Improper Storage Of $3.7M Worth Of Pentavalent Vaccine Ruins Donated Supply, Pakistani Health…

Reuters: Pakistan wastes $3.7 million worth of donated vaccine, official says “Pakistan has wasted $3.7 million worth of vaccines donated to protect children from deadly diseases because officials failed to store them properly, a senior health official told Reuters on Monday. … The ruined vaccines were pentavalent vaccines…” (Hassan, 3/2).


U.S. Response Efforts Against Ebola Were Inadequate, Slow, Presidential Commission On Bioethics…

NBC News: Report Slams U.S. Ebola Response and Readiness “The United States fumbled its response to the Ebola epidemic before it even began, neglecting experiments to make vaccines and drugs against the virus, and cutting funding to key public health agencies, a presidential commission said Thursday. Americans focused on their own almost nonexistent risk of…More


Global Community Needs To Develop, Deliver Vaccines, Treatments To Prevent Under-5 Mortality

PLOS “Speaking of Medicine”: What Kills Little Kids? Peter Hotez, co-editor in chief of PLOS Neglected Tropical Diseases and dean of the National School of Tropical Medicine at Baylor College of Medicine, and Jennifer Herricks of the National School of Tropical Medicine discuss recently released global mortality data from the Global Burden of Disease Study…More


Humanosphere Podcast Examines Global Vaccine Beliefs

Humanosphere: Heidi Larson: The global picture of the ‘vaccine confidence gap’ “For today’s Humanosphere podcast, we’re talking with Heidi Larson, a professor of anthropology at the London School of Hygiene and Tropical Medicine who studies, among other things, public trust (and mistrust) of vaccines…,” Tom Paulson, founder and lead journalist at Humanosphere, writes (2/20).


Older Posts »